Aeon Biopharma Inc.
13F holders, Q2 2024 (June 30)25holders −2
3new positions
5sold out
1famous investor
$0.93avg. 13F price*
At the end of Q2 2024, 25 institutions reported holding Aeon Biopharma Inc. in their 13F filings, down 2 from Q1 2024. 3 opened new positions and 5 sold out. The largest holders were Atalaya Capital Management LP ($3.3M), Polar Asset Management Partners Inc. ($3.3M) and Vanguard Group Inc. ($789K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X100
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $124K |
| Exits | 5 | $420K |
All 13F filers, Q1 2024 → Q2 2024: 267,734 shares bought and 316,388 shares sold, net −48,654 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 25 holders
| Atalaya Capital Management LP | 7.56% | No change | 3,675,000 | $3.3M |
| Polar Asset Management Partners Inc. | 0.13% | No change | 3,675,000 | $3.3M |
| Vanguard Group Inc. | 0.00% | Reduce -1.0% | 751,343 | $789K |
| BlackRock Inc. | 0.00% | Add +6.6% | 272,317 | $286K |
| Ikarian Capital, LLC | 0.08% | No change | 257,977 | $271K |
| Geode Capital Management, LLC | 0.00% | Add +4.0% | 186,858 | $196K |
| Formidable Asset Management, LLC | 0.02% | Add +66.7% | 113,643 | $119K |
| Davidson Kempner Capital Management LP | 0.00% | New | 90,053 | $95K |
| State Street Corp. | 0.00% | Add +2.4% | 60,950 | $64K |
| Boothbay Fund Management, LLC | 0.00% | No change | 55,062 | $58K |
| LMR Partners LLP | 0.00% | Add +731.7% | 54,959 | $58K |
| Northern Trust Corp. | 0.00% | Add +6.4% | 51,928 | $55K |
| Millennium Management | 0.00% | Reduce -8.9% | 50,985 | $54K |
| Jane Street Group, LLC | 0.00% | Reduce -35.8% | 23,273 | $24K |
| Bank of America Corp. | 0.00% | Add +0.7% | 23,150 | $24K |
| Y-Intercept (Hong Kong) Ltd | 0.00% | Add +109.4% | 20,942 | $22K |
| Kim, LLC | 0.00% | New | 15,560 | $16K |
| Dupont Capital Management Corp. | 0.00% | Add +409300.0% | 12,282 | $13K |
| CSS LLC | 0.00% | New | 12,135 | $13K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -93.3% | 11,333 | $12K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +427.9% | 5,105 | $5K |
| Morgan Stanley | 0.00% | Reduce -82.7% | 1,800 | $2K |
| GHP Investment Advisors, Inc. | 0.00% | No change | 1,095 | $1K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -98.2% | 1,056 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.9% | 31 | $33 |
"% of holder's portfolio" is AEON BIOPHARMA INC's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.